SBI Securities »

4d Molecular Therapeutics In shares owned by SBI Securities

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by SBI Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $312 36 8.69
2025-06-30 $130 35 3.71
2025-03-31 $113 35 3.23
2024-12-31 $194 35 5.57

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Tesla Motors (TSLA)
Apple (AAPL)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
Vanguard Total World Stock ETF Etf (VT)
Amazon (AMZN)
Vanguard High Dividend Yield ETF Etf (VYM)
Alphabet Inc Class A cs (GOOGL)
SPDR Portfolio S&P500 HighDividend ETF Etf (SPYD)
Facebook Inc cl a (META)
Direxion Daily Semi Bull 3X Etf (SOXL)

View all positions for SBI Securities

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Vanguard Group
Novo A/S
Henderson Group
Federated Investors
Millennium Management
Armistice Capital
Morgan Stanley
Geode Capital Management
State Street Corporation
Assenagon Asset Management
Two Sigma Advisers

View all funds holding 4d Molecular Therapeutics In